Assessment of progression and regression of coronary atherosclerosis by coronary angiography

被引:0
作者
Erbel, Raimund [1 ]
机构
[1] Univ Duisburg Essen, Univ Klinikum Essen, Westdeutsches Herz & Gefasszentrum Essen, Klin Kardiol, D-45122 Essen, Germany
关键词
Quantitative coronary angiography; Coronary artherosclerosis; Progression; Regression; Statins; ARTERY-DISEASE; INTRAVASCULAR ULTRASOUND; ROSUVASTATIN THERAPY; ATHEROMA; STENOSES; EVENTS; ARTERIOGRAPHY; PRAVASTATIN; DIAMETER; STATIN;
D O I
10.1007/s00059-015-4340-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Quantitative coronary angiography (QCA) has been used for many years to study therapy effects. This became possible after a very high standardization of computer-assisted evaluation of coronary angiograms was introduced. The results of studies with various medications showed that the progression of coronary atherosclerosis could actually be inhibited. Reports on regression were rare and were in the range of 10 % of patients who showed such a response. In recent years only a few studies were carried out with QCA to test the effects of medications. Intravascular ultrasound is the new gold standard for recording coronary atherosclerosis. First rosuvastatin, later fluvastatin and simvastatin and recently rosuvastatin and atorvastatin were tested. Related to the progression and regression of coronary artery sclerosis, the data demonstrated that below a low-density lipoprotein (LDL) cholesterol threshold of 80 mg/dl patients developed regression and above this level progression was predominantly found. These results were similar to the studies using intravascular ultrasound; however, progression and regression are also related to the level of high density lipoprotein (HDL) cholesterol similar again to the level, which could be detected by intravascular ultrasound. Thus, not only intravascular ultrasound but also QCA should be used to study drug interactions with coronary atherosclerosis and particularly when new drugs are compared to statins.
引用
收藏
页码:875 / 882
页数:8
相关论文
共 24 条
  • [1] Suppressive Effects of Standard-dose Rosuvastatin Therapy on the Progression of Coronary Atherosclerosis in Japanese Patients: The APOLLO Study
    Amemiya, Kisaki
    Yokoi, Hiroyoshi
    Domei, Takenori
    Shirai, Shinichi
    Ando, Kenji
    Goya, Masahiko
    Iwabuchi, Masashi
    [J]. JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2014, 21 (12) : 1298 - 1307
  • [2] Effect of rosuvastatin therapy on coronary artery stenoses assessed by quantitative coronary angiography - A study to evaluate the effect of rosuvastatin on intravascular ultrasound-derived coronary atheroma burden
    Ballantyne, Christie M.
    Raichlen, Joel S.
    Nicholls, Stephen J.
    Erbel, Raimund
    Tardif, Jean-Claude
    Brener, Sorin J.
    Cain, Valerie A.
    Nissen, Steven E.
    [J]. CIRCULATION, 2008, 117 (19) : 2458 - 2466
  • [3] Comparison of intravascular ultrasound and quantitative coronary angiography for the assessment of coronary artery disease progression
    Berry, Colin
    L'Allier, Philippe L.
    Gregoire, Jean
    Lesperance, Jacques
    Levesque, Sylvie
    Ibrahim, Reda
    Tardif, Jean-Claude
    [J]. CIRCULATION, 2007, 115 (14) : 1851 - 1857
  • [4] CORONARY ANGIOGRAPHIC CHANGES WITH LOVASTATIN THERAPY - THE MONITORED ATHEROSCLEROSIS REGRESSION STUDY (MARS)
    BLANKENHORN, DH
    AZEN, SP
    KRAMSCH, DM
    MACK, WJ
    CASHINHEMPHILL, L
    HODIS, HN
    DEBOER, LWV
    MAHRER, PR
    MASTELLER, MJ
    VAILAS, LI
    ALAUPOVIC, P
    HIRSCH, LJ
    [J]. ANNALS OF INTERNAL MEDICINE, 1993, 119 (10) : 969 - 976
  • [5] QUANTITATIVE CORONARY ARTERIOGRAPHY - ESTIMATION OF DIMENSIONS, HEMODYNAMIC RESISTANCE, AND ATHEROMA MASS OF CORONARY-ARTERY LESIONS USING ARTERIOGRAM AND DIGITAL COMPUTATION
    BROWN, BG
    BOLSON, E
    FRIMER, M
    DODGE, HT
    [J]. CIRCULATION, 1977, 55 (02) : 329 - 337
  • [6] REGRESSION OF CORONARY-ARTERY DISEASE AS A RESULT OF INTENSIVE LIPID-LOWERING THERAPY IN MEN WITH HIGH-LEVELS OF APOLIPOPROTEIN-B
    BROWN, G
    ALBERS, JJ
    FISHER, LD
    SCHAEFER, SM
    LIN, JT
    KAPLAN, C
    ZHAO, XQ
    BISSON, BD
    FITZPATRICK, VF
    DODGE, HT
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (19) : 1289 - 1298
  • [7] CHANGES IN SEQUENTIAL CORONARY ARTERIOGRAMS AND SUBSEQUENT CORONARY EVENTS
    BUCHWALD, H
    MATTS, JP
    FITCH, LL
    CAMPOS, CT
    SANMARCO, ME
    AMPLATZ, K
    CASTANEDAZUNIGA, WR
    HUNTER, DW
    PEARCE, MB
    BISSETT, JK
    EDMISTON, WA
    SAWIN, HS
    WEBER, FJ
    VARCO, RL
    CAMPBELL, GS
    YELLIN, AE
    SMINK, RD
    LONG, JM
    HANSEN, BJ
    CHALMERS, TC
    MEIER, P
    STAMLER, J
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 268 (11): : 1429 - 1433
  • [8] OBSERVER AGREEMENT IN EVALUATING CORONARY ANGIOGRAMS
    DETRE, KM
    WRIGHT, E
    MURPHY, ML
    TAKARO, T
    [J]. CIRCULATION, 1975, 52 (06) : 979 - 986
  • [9] Effects of fluvastatin on coronary atherosclerosis in patients with mild to moderate cholesterol elevations (lipoprotein and coronary atherosclerosis study [LCAS])
    Herd, JA
    Ballantyne, CM
    Farmer, JA
    Ferguson, JJ
    Jones, PH
    West, S
    Gould, KL
    Gotto, AM
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1997, 80 (03) : 278 - 286
  • [10] EVOLUTION OF CORONARY STENOSES IS RELATED TO BASE-LINE SEVERITY - A PROSPECTIVE QUANTITATIVE ANGIOGRAPHIC ANALYSIS IN PATIENTS WITH MODERATE CORONARY-DISEASE
    JOST, S
    DECKERS, JW
    NIKUTTA, P
    WIESE, B
    RAFFLENBEUL, W
    HECKER, H
    LIPPOLT, P
    LICHTLEN, PR
    [J]. EUROPEAN HEART JOURNAL, 1994, 15 (05) : 648 - 653